Wolverine Trading
NTLA icon

Wolverine Trading’s Intellia Therapeutics NTLA Stock Holding History

Wolverine Trading’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.76M Buy
+163,100
New +$2.01M ﹤0.01% 1894
2025
Q2 		– Sell
-102,200
Closed -$825K – 5312
2025
Q1 		$825K Buy
102,200
+38,200
+60% +$386K ﹤0.01% 2433
2024
Q4 		$730K Buy
64,000
+25,100
+65% +$392K ﹤0.01% 2990
2024
Q3 		$817K Sell
38,900
-8,100
-17% -$187K ﹤0.01% 2564
2024
Q2 		$1.05M Buy
47,000
+22,100
+89% +$526K ﹤0.01% 2153
2024
Q1 		$685K Sell
24,900
-500
-2% -$13.9K ﹤0.01% 2556
2023
Q4 		$774K Sell
25,400
-1,400
-5% -$40.2K ﹤0.01% 2537
2023
Q3 		$847K Buy
26,800
+9,800
+58% +$380K ﹤0.01% 2255
2023
Q2 		$695K Sell
17,000
-500
-3% -$20.3K ﹤0.01% 2323
2023
Q1 		$630K Sell
17,500
-1,500
-8% -$58.8K ﹤0.01% 2290
2022
Q4 		$663K Buy
19,000
+700
+4% +$33.3K ﹤0.01% 2149
2022
Q3 		$1.01M Buy
18,300
+700
+4% +$43.4K ﹤0.01% 1958
2022
Q2 		$923K Buy
17,600
+4,000
+29% +$203K ﹤0.01% 1991
2022
Q1 		$982K Buy
13,600
+2,700
+25% +$229K ﹤0.01% 2455
2021
Q4 		$1.32M Sell
10,900
-1,900
-15% -$238K ﹤0.01% 2309
2021
Q3 		$1.76M Sell
12,800
-15,000
-54% -$2.27M ﹤0.01% 2297
2021
Q2 		$4.21M Buy
27,800
+7,600
+38% +$592K 0.01% 1295
2021
Q1 		$1.46M Buy
+20,200
New +$1.36M ﹤0.01% 2281

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's NTLA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Intellia Therapeutics (NTLA) in Q3 2025: 21,438 shares worth $363K. The stake represents ﹤0.01% of the portfolio and ranks #4105 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in NTLA as recently as Q4 2024.

Wolverine Trading first reported a position in NTLA in Q1 2021 and has held it in 16 quarters since. The position peaked at $901K in Q3 2021. 282 funds tracked by Wall St. Rank hold NTLA as of Q3 2025.

  • Wolverine Trading held 21,438 shares of Intellia Therapeutics worth $363K as of Q3 2025.
  • Intellia Therapeutics was a new Wolverine Trading position in Q3 2025.
  • Intellia Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4105 holding.
  • Wolverine Trading first reported a position in Intellia Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Wolverine Trading's Intellia Therapeutics position peaked at $901K in Q3 2021.
  • 282 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.